INCA / Media Relations Andrea Gilpin Novartis Pharmaceuticals Canada Inc. / Hall & Partners USA LLC / Novartis Group / Novartis Pharmaceuticals Canada Inc. / Novartis AG / Improving / Facebook / /
Country
Switzerland / United States / Canada / /
Currency
USD / / /
Event
Business Partnership / /
Facility
Princess Margaret Cancer Centre / National Cancer Institute / /
IndustryTerm
patient groups / online anonymous survey / over-the-counter and animal health products / through healthcare professionals / generic pharmaceuticals / healthcare field / overall energy levels / healthcare solutions / /
MedicalCondition
neuroendocrine tumours / unusual cancers / NET cancer / Gasteroenteropancreatic Neuroendocrine Tumours / carcinoid / often devastating cancer / cancer / disease / MEN 1 / rare cancer / symptomatic and asymptomatic neuroendocrine tumours / tumour / neuroendocrine tumour diseases / /
MedicalTreatment
surgery / /
Organization
National Cancer Institute / CNETS Canada / International Neuroendocrine Cancer Alliance / North American NeuroEndocrine Tumour Society / US Securities and Exchange Commission / Princess Margaret Cancer Centre in Toronto / Carcinoid NeuroEndocrine Tumour Society Canada / /
Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca